Anthony A. DiTonno
2020
In 2020, Anthony A. DiTonno earned a total compensation of $733.9K as Former Chief Executive Officer at Tenax Therapeutics, a 45% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $221,450 |
|---|---|
| Option Awards | $71,709 |
| Salary | $440,750 |
| Total | $733,909 |
DiTonno received $440.8K in salary, accounting for 60% of the total pay in 2020.
DiTonno also received $221.5K in non-equity incentive plan and $71.7K in option awards.
Rankings
In 2020, Anthony A. DiTonno's compensation ranked 9,816th out of 13,090 executives tracked by ExecPay. In other words, DiTonno earned more than 25.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,816 out of 13,090 | 25th |
Division Manufacturing | 4,220 out of 5,624 | 25th |
Major group Chemicals And Allied Products | 1,730 out of 2,257 | 23rd |
Industry group Drugs | 1,517 out of 1,957 | 23rd |
Industry Pharmaceutical Preparations | 1,119 out of 1,462 | 24th |
Source: SEC filing on April 28, 2022.
DiTonno's colleagues
We found one more compensation record of an executive who worked with Anthony A. DiTonno at Tenax Therapeutics in 2020.
2020
Michael Jebsen
Tenax Therapeutics